Covered recipient · General Payments record
MARINOS C DALAKAS
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$135,663.76
- Reported across 72 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $8,894.00 | 4 |
| Honoraria | $5,000.00 | 2 |
| Travel and Lodging | $1,268.00 | 2 |
| Food and Beverage | $460.20 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Octapharma USA, Inc. | $6,478.16 | 5 |
| ARGENX US, INC. | $4,500.00 | 2 |
| Amgen Inc. | $2,744.00 | 1 |
| UCB SA | $1,650.00 | 1 |
| UCB, Inc. | $250.04 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $2,744.00 | 12/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1117535502 | CMS |
| ARGENX US, INC. | $2,500.00 | 03/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142112837 | CMS |
| ARGENX US, INC. | $2,000.00 | 03/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142112839 | CMS |
| Octapharma USA, Inc. | $1,000.00 | 04/14/2024 | Honoraria | Undisputed | 01/23/2026 | 1142313604 | CMS |
| Octapharma USA, Inc. | $4,000.00 | 04/15/2024 | Honoraria | Undisputed | 01/23/2026 | 1142313606 | CMS |
| Octapharma USA, Inc. | $1,076.00 | 04/15/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142313608 | CMS |
| Octapharma USA, Inc. | $210.16 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142313610 | CMS |
| Octapharma USA, Inc. | $192.00 | 04/15/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142313612 | CMS |
| UCB SA | $1,650.00 | 08/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1113951207 | CMS |
| UCB, Inc. | $118.89 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143209695 | CMS |
| UCB, Inc. | $131.15 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143209700 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.